Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 452


Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study.

Scala C, Leone Roberti Maggiore U, Barra F, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:89-94. doi: 10.1016/j.ejogrb.2018.01.022. Epub 2018 Feb 3.


Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.

Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.

Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.


Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol).

Richarz NA, Aguilera J, Castillo G, Fuente MJ, Ferrándiz C, Carrascosa JM.

Photochem Photobiol Sci. 2017 Sep 13;16(9):1381-1383. doi: 10.1039/c7pp00160f.


Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.

Hasegawa S, Matsui T, Hane Y, Abe J, Hatahira H, Motooka Y, Sasaoka S, Fukuda A, Naganuma M, Hirade K, Takahashi Y, Kinosada Y, Nakamura M.

PLoS One. 2017 Jul 21;12(7):e0182045. doi: 10.1371/journal.pone.0182045. eCollection 2017.


[Efficacy and impact on quality of life of different drug treatments after partial resection of rectovaginal endometriosis].

Li T, Xu XX, Dai Y, Zhang JJ, Lang JH, Leng JH.

Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):307-313. doi: 10.3760/cma.j.issn.0529-567X.2017.05.004. Chinese.


Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats.

Olatunji LA, Olaniyi KS, Usman TO, Abolarinwa BA, Achile CJ, Kim IK.

Environ Toxicol Pharmacol. 2017 Jun;52:54-61. doi: 10.1016/j.etap.2017.03.012. Epub 2017 Mar 20.


Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.

Olatunji LA, Michael OS, Adeyanju OA, Areola ED, Soladoye AO.

Pharmacol Rep. 2017 Jun;69(3):512-519. doi: 10.1016/j.pharep.2016.12.010. Epub 2016 Dec 19.


No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.

Marshall WL, Feng HP, Caro L, Talaty J, Guo Z, Huang X, Panebianco D, Ma J, Mangin E, O'Reilly TE, Butterton JR, Yeh WW.

Eur J Clin Pharmacol. 2017 May;73(5):593-600. doi: 10.1007/s00228-017-2216-4. Epub 2017 Feb 24.


Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Westhoff CL, Pike MC, Cremers S, Eisenberger A, Thomassen S, Rosing J.

Contraception. 2017 May;95(5):456-463. doi: 10.1016/j.contraception.2017.01.001. Epub 2017 Jan 11.


Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.

Trezza C, Ford SL, Gould E, Lou Y, Huang C, Ritter JM, Buchanan AM, Spreen W, Patel P.

Br J Clin Pharmacol. 2017 Jul;83(7):1499-1505. doi: 10.1111/bcp.13236. Epub 2017 Feb 14.


Estimating systemic exposure to levonorgestrel from an oral contraceptive.

Basaraba CN, Westhoff CL, Pike MC, Nandakumar R, Cremers S.

Contraception. 2017 Apr;95(4):398-404. doi: 10.1016/j.contraception.2016.12.007. Epub 2016 Dec 30.


Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.

Priya K, Rajaram S, Goel N.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:141-146. doi: 10.1016/j.ejogrb.2016.10.026. Epub 2016 Nov 8.


Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial.

Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B, Johannesson M, Hirschberg AL.

J Clin Endocrinol Metab. 2016 Nov;101(11):4046-4053. Epub 2016 Aug 15.


Clarification of contraceptive drug pharmacokinetics in obesity.

Jusko WJ.

Contraception. 2017 Jan;95(1):10-16. doi: 10.1016/j.contraception.2016.08.003. Epub 2016 Aug 16. Review.


Additive effects of levonorgestrel and ethinylestradiol on brain aromatase (cyp19a1b) in zebrafish specific in vitro and in vivo bioassays.

Hinfray N, Tebby C, Garoche C, Piccini B, Bourgine G, Aït-Aïssa S, Kah O, Pakdel F, Brion F.

Toxicol Appl Pharmacol. 2016 Sep 15;307:108-114. doi: 10.1016/j.taap.2016.07.023. Epub 2016 Aug 1.


Perspectives on variability in pharmacokinetics of an oral contraceptive product.

Jusko WJ.

Contraception. 2017 Jan;95(1):5-9. doi: 10.1016/j.contraception.2016.07.019. Epub 2016 Jul 27. Review.


Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.

Contraception. 2017 Nov;96(5):322-329. doi: 10.1016/j.contraception.2016.06.022. Epub 2016 Jul 5.


Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.

Yousuf SD, Rashid F, Mattoo T, Shekhar C, Mudassar S, Zargar MA, Ganie MA.

J Pediatr Adolesc Gynecol. 2017 Feb;30(1):58-62. doi: 10.1016/j.jpag.2016.06.010. Epub 2016 Jul 2.


Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.

Gersten J, Hsieh J, Weiss H, Ricciotti NA.

J Pediatr Adolesc Gynecol. 2016 Dec;29(6):635-642. doi: 10.1016/j.jpag.2016.05.012. Epub 2016 Jun 7.


Supplemental Content

Loading ...
Support Center